This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Illinois officials recently released the Annual Cannabis Report for Fiscal Year 2024. The focus of the subsequent three meetings was the examination of conditions under consideration for addition to the list of debilitating conditions that are qualifying for participation in the Medical Cannabis Patient Program (MCPP).
Illinois officials recently released the Annual Cannabis Report for Fiscal Year 2024. IDFPR is also committed to working with those who received Conditional Adult Use Dispensing Organization licenses in 2023’s Social Equity Criteria Lottery to open their doors as new dispensaries and begin serving customers.
MCAB members voted to recommend Uterine Fibroid and Painful Uterine Fibroid but did not recommend Generalized Anxiety as a qualifying debilitating condition. After back-and-forth discussion, board members first voted 7-0 to approve Uterine Fibroid as a qualifying debilitating condition. Subieta Benito abstained from the vote.
The agenda includes discussions and votes regarding the last two proposed qualifying debilitating conditions, Uterine Fibroid and Generalized Anxiety. MCAB has scheduled its July meeting for Monday, July 22, 2024, 3-5 p.m., To find cannabis-friendly events in Illinois, visit here. For Illinois News Joint reviews, visit here.
Part I of this series detailed the difficult, time consuming, and courageous work behind the process of how the Illinois Department of Public Health (IDPH) added female orgasmic disorder to the list of qualifying debilitating condition for medical patients in the Compassionate Use of Medical Cannabis Program.
The agenda includes discussions regarding four newly proposed qualifying debilitating conditions. MCAB is considering Ovarian Cyst, Polycystic Ovarian Syndrome, Uterine Fibroid, and Generalized Anxiety as new qualifying debilitating conditions for medical cannabis patients in Illinois. Monday, June 10, 2024. Monday, May 13.
The 20-page report included a summary, 2023 accomplishments, goals for fiscal year 2024, and several charts and statistics. In nearly four years, IDFPR has issued 48 social total equity dispensary licenses and conducted the SECL for 55 more conditional licenses that included almost 2,700 entrants.
During the legislative session in May 2024, lawmakers failed to bring to a final vote two cannabis bills in the Illinois House ( House Bill 4293 , the Hemp Consumer Products Act, and House Bill 2911 , a cannabis omnibus). To find cannabis-friendly events in Illinois, visit here. For Illinois News Joint reviews, visit here.
The Academic Cannabis Conference , produced by News Joint Events , is pleased to announce its full presenter lineup and schedule. at the Garden Grove Event Center in Carbondale on May 4. The event is runs from 12-5 p.m., To find more cannabis-friendly events in Illinois, visit here. 3:30 p.m. – 3:30 p.m. – Marialle A.
Another provision requires the Illinois Department of Agriculture to issue an additional 30 craft grower licenses on or before May 1, 2023 and an additional 30 craft grower licenses on or before September 1, 2024 under specified conditions. 2) During calendar year 2024, 60,000 grams per month. (3)
In addition, board members discussed bylaws, expectation of board members, and the overall influence MCAB would have on politicians, lawmaking, accepted debilitating medical conditions, and the Compassionate Use of Medical Cannabis Program overall. The next meeting is scheduled for February 2024.
If the proposal — which was sponsored by Rules Committee Chairman Bill Rabon (R) — is enacted into law, patients who are diagnosed with a “debilitating medical condition” could legally gain access to medical cannabis in North Carolina. About the NC Medical Cannabis Legalization Bill.
By 2024, the medicinal cannabis market within the United Kingdom is predicted to be worth nearly US$1.3 Jersey, Channel Islands, which is known to have one of the highest GDP per capita in the world , is a British dependency island ideally situated in the English Channel off the coast of France. in real terms to £4.97
The press release stated, “This milestone was achieved nearly two weeks faster in 2024 compared to 2023, when the $1 billion sales mark was not reached until July 10. Additionally, Fiscal Year 2024 saw total cannabis sales exceed $2 billion, which represents an increase from Fiscal Year 2023 ($1.9 billion) and Fiscal Year 2022 ($1.8
Requires the Department of Agriculture to issue an additional 30 craft grower licenses on or before May 1, 2023 and an additional 30 craft grower licenses on or before September 1, 2024 under specified conditions. To learn about cannabis-friendly events in Illinois, visit here. The other bill is HB0030, also sponsored by Ford.
The medicinal cannabis market within the United Kingdom keeps growing and by 2024 it is predicted to be worth nearly US$1.3 We continue to evolve our product and software solutions to help clinicians and researchers unlock breakthroughs in clinical research and analytics,” said Gregory Wagner, CEO of RYAH Group, Inc.
Forward-looking information is necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information.
cannabis legalization (or Tilray’s waiver of such condition).In cannabis legalization (or Tilray’s waiver of such condition).In market conditions, future strategic planning, the business and prospects of the MedMen and any other factors that Tilray or the SPV, as applicable, may consider relevant from time to time.?.
Eligible applicants must be social equity Conditional and Adult Use Dispensing Organizations licensed by the Illinois Department of Finance and Professional Regulation (IDFPR). Applications for this round of loans will be accepted until April 17, 2024, at 5:00 p.m. To find cannabis-friendly events in Illinois, visit here.
cannabis legalization (or Tilray’s waiver of such condition).In Simon, Tilray’s Chairman and CEO, said, “Backed by accelerating trends towards legalization globally, we are focused on building the world’s leading cannabis-focused consumer branded company with a goal of $4 billion of revenue by the end of our fiscal 2024.
Insomnia (difficulty falling or staying asleep) is a pervasive medical condition, affecting nearly a third of all adults globally. A Prevalent Condition – In our introduction, we already mentioned that a third of adults struggle with sleeplessness. Retrieved June 10, 2024, from [link] Modern Canna Labs.
Marijuana Business Daily projects that the state’s recreational market could generate up to $400 million in revenue its first year and more than $700 million by 2024.”. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties.
In addition, board members discussed bylaws, expectation of board members, and the overall influence MCAB would have on politicians, lawmaking, accepted debilitating medical conditions, and the Compassionate Use of Medical Cannabis Program overall. The Medical Cannabis Advisory Board has set its third meeting date for August 2024.
The country hosts several cannabis events, including Cannafest in Prague , Konopex in Ostrava , and the Million Marihuana March. After Germany announced plans to legalize the plant, Czechia followed suit, with the first draft of legislation expected early in the 2023 session and tentative legalization in 2024. Possible penalties.
Under this bill, the Veterinary Medical Board is required to adopt guidelines, by January 1, 2024, for veterinarians to follow when recommending cannabis within the veterinarian-client-patient relationship, and would require the Veterinary Medical Board to post the guidelines on its internet website. on the day after the event has ended.
(the “Company”) (NYSE: IIPR) announced today that its operating partnership, IIP Operating Partnership, LP (the “Operating Partnership”), has commenced a public offering, subject to market and other conditions, of $300 million aggregate principal amount of senior notes due 2027 (the “notes”). Catherine Hastings. Chief Financial Officer.
Forecasts state that the medical marijuana market will be worth more than $8 billion by 2024, and the global medical cannabis market is predicted to reach a net worth of $73.6 Even in this event, you might still want to see a medical marijuana doctor. These are just a few of the main qualifying conditions. billion by 2027.
Further bulletins as events warrant. When we last reported on the Empire State, an application window had just been opened, and licenses were expected in early 2024. This week, we note that a lawsuit preventing conditional adult-use retail dispensary licensees from opening dispensaries has now been settled.
” A recent industry report from Research and Markets suggests the global cigarette market will be valued at an estimated US $1,124 billion by 2024, and is expected to grow at a 4% CAGR over the next five years.
By 2024, the CBD market in China alone is forecasted to be worth USD $15 billion, according to Hong Kong-based investment company Regent Pacific Group, citing the beauty and wellness sector as the main driver. These statements relate to future events or future performance.
Nadav Kidron, Oramed CEO and Oravax Chairman, and Rodrigo Herrera, Genomma Lab Chairman, will hold a joint press event today, Thursday, November 18, 2021 at 11:00 am EST. The live press event will be available via Zoom. 19 vaccine candidate in Mexico. MyMD: Robert Schatz. 646) 421-9523. rschatz@mymd.com www.mymd.com.
The Company may redeem the 2026 Notes at par, in whole or in part, on or after February 3, 2024, as more particularly described in the fourth supplemental trust indenture governing the 2026 Notes. The 2026 Notes accrue interest payable semi-annually in arrears and mature on February 3, 2026, unless earlier redeemed or repurchased.
“Despite delivering modest growth in our core medical and consumer business in Q2, we took immediate and deliberate actions to align our Company to current market conditions,” said Michael Singer , Executive Chairman and Interim CEO, Aurora Cannabis. Subsequent Events & Business Transformation Plan. Q1 2020 (4).
Colombia President Ivan Duque signed a decree ending “the ban on the export of dried flower” in an event organized at a facility owned by Clever Leaves, one of the 18 multinationals that grows medicinal cannabis in Colombia. National and international companies have invested US$250mn in Colombia to develop this industry.
Colombia President Ivan Duque signed a decree ending “the ban on the export of dried flower” in an event organized at a facility owned by Clever Leaves, one of the 18 multinationals that grows medicinal cannabis in Colombia. National and international companies have invested US$250mn in Colombia to develop this industry.
Colombia President Ivan Duque signed a decree ending “the ban on the export of dried flower” in an event organized at a facility owned by Clever Leaves, one of the 18 multinationals that grows medicinal cannabis in Colombia. National and international companies have invested US$250mn in Colombia to develop this industry.
The issuance of the Common Shares in lieu of cash is subject to the terms and conditions of the indentures as well as the receipt of all requisite approvals, including, without limitation, the approval of the CSE. Any Common Shares issued to a holder of the debentures in the United States will be restricted securities under the U.S.
As skateboarding can be such a physically demanding sport, it’s no surprise some skateboarders choose to use cannabis to address these conditions and more. In fact, both the hip-hop and skateboarding scenes placed emphasis on competitive events in the streets.
Colombia President Ivan Duque signed a decree ending “the ban on the export of dried flower” in an event organized at a facility owned by Clever Leaves, one of the 18 multinationals that grows medicinal cannabis in Colombia. National and international companies have invested US$250mn in Colombia to develop this industry.
billion by 2024. looking information is not based on historical facts but instead reflect the Company’s management’s expectations, estimates or projections concerning the business of the Company’s future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made.
Our readers and followers reacted the most to the one positive story about the Illinois Department of Public Health (IDPH) adding four new conditions to the list of qualifying debilitating condition for medical patients in the Compassionate Use of Medical Cannabis Program. 7, 2023, but did not meet again until March 11, 2024.
MCAB board members took preliminary votes to include two qualifying debilitating conditions for medical cannabis patients in Illinois. After public comment, board members voted anonymously via private messages for two new conditions to be added, endometrioses and FOD (Female Organismic Disorder).
Governor Kevin Stitt signed legislation enacting a moratorium on some new medical marijuana licenses, effective on August 1, 2022 and ending August 1, 2024. Sets a date of July 1, 2024 for automatic expungement of cannabis possession convictions. The moratorium expires March 31, 2024. Development. May 26, 2022. Processors.
Governor Kevin Stitt signed legislation enacting a moratorium on some new medical marijuana licenses, effective on August 1, 2022 and ending August 1, 2024. Sets a date of July 1, 2024 for automatic expungement of cannabis possession convictions. The moratorium expires March 31, 2024. Development. May 26, 2022. Processors.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content